H
Hanqiu Song
Researcher at University of California, San Francisco
Publications - 4
Citations - 1580
Hanqiu Song is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Angiogenesis & Vascular endothelial growth factor A. The author has an hindex of 4, co-authored 4 publications receiving 1489 citations.
Papers
More filters
Journal ArticleDOI
HIF1α Induces the Recruitment of Bone Marrow-Derived Vascular Modulatory Cells to Regulate Tumor Angiogenesis and Invasion
Rose Du,Kan V. Lu,Claudia Petritsch,Patty Liu,Ruth Ganss,Emmanuelle Passegué,Hanqiu Song,Scott R. VandenBerg,Randall S. Johnson,Zena Werb,Gabriele Bergers +10 more
TL;DR: It is demonstrated that HIF1alpha, the direct effector of hypoxia, partly through increases in SDF1 alpha, induces recruitment of bone marrow-derived CD45+ myeloid cells containing Tie2+, VEGFR1+, CD11b+, and F4/80+ subpopulations, as well as endothelial and pericyte progenitor cells to promote neovascularization in glioblastoma.
Journal ArticleDOI
The hypoxic response of tumors is dependent on their microenvironment
Barbara Blouw,Hanqiu Song,Tarik Tihan,Jenel Bosze,Napoleone Ferrara,Hans-Peter Gerber,Randall S. Johnson,Gabriele Bergers +7 more
TL;DR: It is demonstrated that HIF-1alpha has differential roles in tumor progression, which are greatly dependent on the extant microenvironment of the tumor.
Journal ArticleDOI
Matrix metalloproteinase-2 regulates vascular patterning and growth affecting tumor cell survival and invasion in GBM.
Rose Du,Claudia Petritsch,Kan Lu,Patty H. Liu,Anna Haller,Ruth Ganss,Hanqiu Song,Scott R. VandenBerg,Gabriele Bergers +8 more
TL;DR: Surprisingly, despite the high vascular density, tumor cells were more prone to apoptosis, which led to prolonged survival of tumor-bearing mice, suggesting that the increased vascularity is not functional, and MMP-2-dependent effects appeared to be dose-dependent irrespective of its expression pattern.
Journal ArticleDOI
Loss of vascular endothelial growth factor expression reduces vascularization, but not growth, of tumors lacking the Von Hippel-Lindau tumor suppressor gene.
TL;DR: Antiangiogenic therapies for tumors that express high levels of angiogenic factors such as VEGF may vary in their efficacy, with potentially lowered effectiveness in sites, such as the brain, that are inherently vessel rich.